JSR

JSR Corporation, headquartered in Tokyo, Japan, is a prominent player in the petrochemical and fine chemicals sectors, with a significant presence in regions including South Korea, China, and the United States. The company operates through four main segments: elastomers, plastics, digital solutions, and life sciences. Its elastomers segment offers a variety of synthetic rubbers, thermoplastic elastomers, and emulsions, generating the highest revenue. The plastics segment encompasses synthetic resins such as ABS and AES. The digital solutions segment focuses on semiconductor materials and display materials, while the life sciences segment provides research and diagnostic reagents, bioprocess materials, and medical products. Founded in 1957, JSR Corporation has evolved to meet diverse industry needs, including advanced materials for electronics and healthcare applications.

Eric R. Johnson

CEO

23 past transactions

CropIn

Series D in 2022
Cropin, established in 2010, is a leader in the Agtech sector, renowned for developing the first global Intelligent Agriculture Cloud. Its platform empowers stakeholders in the agricultural ecosystem to utilize digitization and artificial intelligence, enhancing efficiency, productivity, and sustainability. Cropin has partnered with over 250 clients and has digitized 16 million acres of farmland, positively impacting the livelihoods of more than 7 million farmers. The company has amassed extensive farming data, covering 488 crops and 10,000 crop varieties across 56 countries, and has established a global 'Ag-intelligence' movement. Additionally, Cropin's farm management software integrates agriculture with information and communication technology, facilitating data-driven practices. This software supports various participants in the agricultural value chain, improving financial and operational outcomes while ensuring food quality and safety for consumers.

Inpria

Acquisition in 2021
Inpria Corporation is a company based in Corvallis, Oregon, that specializes in the design, development, and manufacturing of EUV metal oxide photoresists for the semiconductor industry. Founded in 2007, Inpria is recognized for its innovative approach to extending semiconductor lithography through inorganic photoresists and thin films for nanoscale patterning. The company's patented photo-condensed molecular oxides allow for the direct deposition of atomically smooth and dense metal oxide films from solution, which can be photopatterned for advanced applications. Inpria's photoresists are meticulously designed to meet rigorous industry specifications, addressing key factors such as resolution, sensitivity, and line width roughness, while integrating seamlessly into manufacturing processes. This holistic approach provides customers with a comprehensive solution that includes photoresists, developers, and related materials.

Fluence Analytics

Venture Round in 2021
Fluence Analytics, Inc. specializes in manufacturing monitoring solutions for industrial and laboratory settings, focusing on the measurement and analysis of polymer production processes. The company provides a system that analyzes polymers during production and a light scattering instrument designed to assess the stability of therapeutic proteins and the quality of both natural and synthetic polymers. By generating continuous data streams and employing proprietary analytical tools, Fluence Analytics enables real-time optimization of process control and accelerates research and development for its clients in the polymer and biopharmaceutical sectors. Founded in 2012 and based in New Orleans, Louisiana, the company was previously known as Advanced Polymer Monitoring Technologies, Inc. before rebranding in April 2017.

Vedanta Biosciences

Series D in 2021
Vedanta Biosciences, Inc. is a clinical-stage microbiome company based in Cambridge, Massachusetts, focused on developing therapies for immune-mediated and infectious diseases using human microbiome-derived bacteria. Established in 2010, the company utilizes microbial ecology and mucosal immunology to create innovative immunotherapies. Its platform includes a comprehensive library of bacteria sourced from the human microbiome, proprietary assays for selecting effective bacterial strains, and extensive datasets from human interventional studies. Vedanta also possesses cGMP-compliant manufacturing capabilities, allowing for the production of defined bacterial consortia in powder form. This enables the development of oral therapies aimed at treating autoimmune and inflammatory diseases, providing physicians with effective access to live bacterial drugs. Vedanta operates as a subsidiary of Pure Tech Health plc.

Iridia

Series B in 2021
Iridia, Inc. is a nanotechnology company based in Carlsbad, California, that specializes in innovative data storage solutions utilizing DNA. Founded in 2016, the company has developed a groundbreaking technology that allows for the reading and writing of data in DNA, leveraging semiconductor fabrication and proprietary enzymology. By integrating DNA polymer synthesis technology with electronic nano-switches, Iridia offers a highly parallel format capable of storing data at exceptionally high densities. This advancement not only reduces the infrastructure requirements for data storage but also addresses environmental concerns associated with traditional storage methods. Iridia aims to provide an affordable and efficient means for businesses to manage large volumes of data sustainably.

AlphaICs

Series B in 2021
AlphaICs India Private Limited specializes in developing artificial intelligence system on a chip (SoC) solutions, offering purpose-built SoCs, FPGA boards, and deep learning chips for various applications. Founded in 2016 and based in Bengaluru, the company focuses on sectors such as home automation, healthcare wearables, industrial automation, drones, and IoT systems. AlphaICs is advancing AI computing with its patented RAP (Real AI Processing) technology, which is designed to enhance the performance of autonomous systems like self-driving cars, robotics, and intelligent cloud computing. The company emphasizes edge inference and edge learning technologies, enabling efficient AI processing with high performance, low power consumption, and minimal latency. This approach aims to support clients in accelerating AI workloads while optimizing data management and continuous learning capabilities at the edge.

Cambridge Quantum Computing

Venture Round in 2020
Cambridge Quantum Computing Limited is a quantum computing software company based in Cambridge, United Kingdom, with additional operations in London, Chessington, San Francisco, Washington D.C., and Tokyo. Founded in 2014, the company focuses on developing tools to facilitate the commercialization of quantum technologies. Its key offerings include t|ket, a quantum development platform; EUMEN, which targets quantum chemistry applications; QML for quantum machine learning; and IronBridge, aimed at enhancing cybersecurity through quantum methods. Cambridge Quantum Computing aims to provide effective solutions for both corporate and government applications, leveraging its expertise in quantum protocols and algorithms to advance the practical use of quantum computing as the technology matures.

Inpria

Series C in 2020
Inpria Corporation is a company based in Corvallis, Oregon, that specializes in the design, development, and manufacturing of EUV metal oxide photoresists for the semiconductor industry. Founded in 2007, Inpria is recognized for its innovative approach to extending semiconductor lithography through inorganic photoresists and thin films for nanoscale patterning. The company's patented photo-condensed molecular oxides allow for the direct deposition of atomically smooth and dense metal oxide films from solution, which can be photopatterned for advanced applications. Inpria's photoresists are meticulously designed to meet rigorous industry specifications, addressing key factors such as resolution, sensitivity, and line width roughness, while integrating seamlessly into manufacturing processes. This holistic approach provides customers with a comprehensive solution that includes photoresists, developers, and related materials.

Carbon

Series E in 2019
Carbon, Inc. is a technology company based in Redwood City, California, that specializes in advanced digital manufacturing solutions. Founded in 2013, Carbon designs and manufactures a range of products, including its proprietary Digital Light Synthesis technology, which utilizes digital light projection and programmable liquid resins to create high-quality parts with superior mechanical properties and surface finishes. The company also offers SpeedCell, a connected manufacturing system that facilitates the consistent production of end-use parts at scale, along with automated solutions like the Smart Part Washer. Carbon provides various materials, such as rigid and flexible polyurethanes, cyanate esters, and epoxies, serving diverse industries including automotive, consumer products, dental, industrial, and life sciences. By leveraging its Continuous Liquid Interface Production Technology, Carbon enables manufacturers to pursue innovative business models, including mass customization and on-demand inventory, while reducing tooling costs and accelerating time to market.

Cambridge Quantum Computing

Funding Round in 2019
Cambridge Quantum Computing Limited is a quantum computing software company based in Cambridge, United Kingdom, with additional operations in London, Chessington, San Francisco, Washington D.C., and Tokyo. Founded in 2014, the company focuses on developing tools to facilitate the commercialization of quantum technologies. Its key offerings include t|ket, a quantum development platform; EUMEN, which targets quantum chemistry applications; QML for quantum machine learning; and IronBridge, aimed at enhancing cybersecurity through quantum methods. Cambridge Quantum Computing aims to provide effective solutions for both corporate and government applications, leveraging its expertise in quantum protocols and algorithms to advance the practical use of quantum computing as the technology matures.

Mattrix Technologies

Series A in 2019
Mattrix Technologies Inc., founded in 2018 and based in Gainesville, Florida, specializes in the development and manufacturing of full-aperture organic light emitting transistor (OLET) displays. The company offers a unique pixel architecture that integrates the drive transistor, storage capacitor, and light-emitting layers into a vertically stacked, transparent configuration. This innovative approach addresses the limitations of traditional OLED backplane technology, facilitating the production of large-area displays at a reduced cost and simplifying the manufacturing process. By providing a high aperture ratio and bottom emission capabilities, Mattrix Technologies aims to enhance the performance and adoption of emissive display technologies.

Vedanta Biosciences

Series C in 2019
Vedanta Biosciences, Inc. is a clinical-stage microbiome company based in Cambridge, Massachusetts, focused on developing therapies for immune-mediated and infectious diseases using human microbiome-derived bacteria. Established in 2010, the company utilizes microbial ecology and mucosal immunology to create innovative immunotherapies. Its platform includes a comprehensive library of bacteria sourced from the human microbiome, proprietary assays for selecting effective bacterial strains, and extensive datasets from human interventional studies. Vedanta also possesses cGMP-compliant manufacturing capabilities, allowing for the production of defined bacterial consortia in powder form. This enables the development of oral therapies aimed at treating autoimmune and inflammatory diseases, providing physicians with effective access to live bacterial drugs. Vedanta operates as a subsidiary of Pure Tech Health plc.

FLOSFIA

Corporate Round in 2019
FLOSFIA INC. is a Tokyo-based company that specializes in developing corundum structured Gallium Oxide semiconductor power devices. Founded on March 31, 2011, as a spin-off from research at Kyoto University, the company focuses on film formation through mist chemical vapor deposition. FLOSFIA's products are characterized by high breakdown voltage and efficiency, aimed at creating low-loss power devices that leverage the advantageous properties of gallium oxide (Ga2O3).

Absci

Series D in 2019
Absci is a drug and target discovery company that leverages deep learning AI and synthetic biology to enhance the therapeutic potential of proteins. Its Integrated Drug Creation Platform streamlines the process of identifying novel drug targets, discovering optimal biotherapeutic candidates, and generating the necessary cell lines for manufacturing. By combining biologic drug discovery and cell line development into a single, efficient workflow, Absci collaborates with biotech and pharmaceutical innovators to develop next-generation protein-based drugs. These innovations include Bionic Proteins, which feature nonstandard amino acids, and other unique drug designs that may be unattainable through conventional methods. Absci's mission is to facilitate the development of improved medicines by effectively translating innovative ideas into viable drugs.

Cambridge Quantum Computing

Funding Round in 2018
Cambridge Quantum Computing Limited is a quantum computing software company based in Cambridge, United Kingdom, with additional operations in London, Chessington, San Francisco, Washington D.C., and Tokyo. Founded in 2014, the company focuses on developing tools to facilitate the commercialization of quantum technologies. Its key offerings include t|ket, a quantum development platform; EUMEN, which targets quantum chemistry applications; QML for quantum machine learning; and IronBridge, aimed at enhancing cybersecurity through quantum methods. Cambridge Quantum Computing aims to provide effective solutions for both corporate and government applications, leveraging its expertise in quantum protocols and algorithms to advance the practical use of quantum computing as the technology matures.

Carbon

Series D in 2017
Carbon, Inc. is a technology company based in Redwood City, California, that specializes in advanced digital manufacturing solutions. Founded in 2013, Carbon designs and manufactures a range of products, including its proprietary Digital Light Synthesis technology, which utilizes digital light projection and programmable liquid resins to create high-quality parts with superior mechanical properties and surface finishes. The company also offers SpeedCell, a connected manufacturing system that facilitates the consistent production of end-use parts at scale, along with automated solutions like the Smart Part Washer. Carbon provides various materials, such as rigid and flexible polyurethanes, cyanate esters, and epoxies, serving diverse industries including automotive, consumer products, dental, industrial, and life sciences. By leveraging its Continuous Liquid Interface Production Technology, Carbon enables manufacturers to pursue innovative business models, including mass customization and on-demand inventory, while reducing tooling costs and accelerating time to market.

Thermalin

Series A in 2017
Thermalin, Inc. is a biotechnology company based in Cleveland, Ohio, founded in 2010, that specializes in developing innovative insulin therapies for individuals with Type 1 and Type 2 diabetes. The company aims to disrupt the insulin and insulin delivery market with its first-in-class, ultra-rapid acting insulin, which is stabilized and highly concentrated. This new insulin formulation is designed for use in a disposable, postage-stamp-sized glucose management system and can also be utilized in existing insulin pumps. In addition to its lead program, Thermalin is exploring partnerships to develop no-cold-chain basal and mix insulins, as well as glucose-responsive insulins. By creating insulin analogs that do not require refrigeration and are rapidly absorbed, Thermalin seeks to reduce the burden of insulin therapy, thereby improving patient adherence and health outcomes.

Lexi

Acquisition in 2017
LEXI Co., Ltd., based in Tokyo, Japan, specializes in developing medical software and hardware focused on scientific visualization and simulation. Founded in 1988, the company provides advanced 3D pre-operative planning orthopedic software designed for total and partial hip and knee arthroplasty, as well as osteotomy procedures. This software, which is CE-marked and FDA-cleared, is utilized in over 250 medical institutions across Japan. By facilitating detailed surgical planning in a 3D environment, LEXI's solutions enhance the performance of surgeons and improve the quality of life for patients. The company operates under a quality management system certified to ISO 13485 standards and is a subsidiary of JSR Corporation since 2017.

Inpria

Series B in 2017
Inpria Corporation is a company based in Corvallis, Oregon, that specializes in the design, development, and manufacturing of EUV metal oxide photoresists for the semiconductor industry. Founded in 2007, Inpria is recognized for its innovative approach to extending semiconductor lithography through inorganic photoresists and thin films for nanoscale patterning. The company's patented photo-condensed molecular oxides allow for the direct deposition of atomically smooth and dense metal oxide films from solution, which can be photopatterned for advanced applications. Inpria's photoresists are meticulously designed to meet rigorous industry specifications, addressing key factors such as resolution, sensitivity, and line width roughness, while integrating seamlessly into manufacturing processes. This holistic approach provides customers with a comprehensive solution that includes photoresists, developers, and related materials.

Light Polymers

Series B in 2017
Light Polymers Inc. is a materials company specializing in the synthesis and development of self-aligning lyotropic liquid crystal solutions. Founded in 2006 and headquartered in South San Francisco, California, with additional facilities in Silicon Valley and Taiwan, the company focuses on applications in flat panel displays, LED lighting, smart glass, solar technologies, and horticultural lighting. Its innovative materials address significant challenges in the flat panel display industry, particularly in the production of optical film polarizers, which traditionally require complex and costly processes. Light Polymers' products enable the creation of thin, coatable polarizers that enhance brightness and efficiency for ultra-high-definition displays, while also aligning with market trends in flexible and transparent technologies. The company’s solutions cater to various sectors, offering customers advanced materials for optical films, specialty plastics, and manufacturing processes.

Selexis

Acquisition in 2017
Selexis is a life sciences company that specializes in mammalian cell line generation, utilizing advanced technologies to enhance the production of recombinant proteins and monoclonal antibodies. By focusing on suspension-adapted CHO-K1 cell lines, Selexis provides essential tools and expertise to biopharmaceutical companies, facilitating the development of innovative therapies. The company's proprietary methods aim to streamline the drug development and manufacturing process, ultimately translating scientific advancements into effective medicines for patients. Through its commitment to improving the expression of biopharmaceuticals, Selexis plays a critical role in the life sciences sector, supporting the creation of life-saving treatments.

Carbon

Series C in 2016
Carbon, Inc. is a technology company based in Redwood City, California, that specializes in advanced digital manufacturing solutions. Founded in 2013, Carbon designs and manufactures a range of products, including its proprietary Digital Light Synthesis technology, which utilizes digital light projection and programmable liquid resins to create high-quality parts with superior mechanical properties and surface finishes. The company also offers SpeedCell, a connected manufacturing system that facilitates the consistent production of end-use parts at scale, along with automated solutions like the Smart Part Washer. Carbon provides various materials, such as rigid and flexible polyurethanes, cyanate esters, and epoxies, serving diverse industries including automotive, consumer products, dental, industrial, and life sciences. By leveraging its Continuous Liquid Interface Production Technology, Carbon enables manufacturers to pursue innovative business models, including mass customization and on-demand inventory, while reducing tooling costs and accelerating time to market.

Lehigh Technologies

Venture Round in 2014
Lehigh Technologies, Inc. is a specialty chemicals company that produces micronized rubber powders from end-of-life tires and post-industrial rubber, offering sustainable and cost-effective alternatives to traditional oil- and rubber-based feedstocks. The company's key products include MicroDyne and PolyDyne, which are tailored to meet the specific needs of various industries, including tires, plastics, construction materials, and asphalt. Lehigh also provides EkoDyne for chemical devulcanization and functionalization, Rheopave, a blend of polymers, and Zenoflex, a thermoplastic elastomer that combines micronized rubber with custom polymers. With a major manufacturing facility near Atlanta and a research and development center for advanced applications, Lehigh Technologies serves a global customer base and emphasizes closed-loop services that enhance product performance and sustainability. Founded in 2003 and headquartered in Tucker, Georgia, the company also has a subsidiary in Barcelona, Spain, and a production plant in Navarra, Spain.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.